Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma

Overview of attention for article published in Acta Neuropathologica Communications, August 2018

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 792 followers.

Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma https://t.co/hj318IdBzt

Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma. - PubMed - NCBI https://t.co/g23DXhX3Lh

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.